Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature
Top Cited Papers
- 13 September 2019
- journal article
- research article
- Published by Elsevier BV in Cytotherapy
- Vol. 21 (10), 1019-1024
- https://doi.org/10.1016/j.jcyt.2019.08.002
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived CounterpartsStem Cells Translational Medicine, 2013
- The Tunica Adventitia of Human Arteries and Veins As a Source of Mesenchymal Stem CellsStem Cells and Development, 2012
- Multipotent mesenchymal stromal cells and the innate immune systemNature Reviews Immunology, 2012
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- The MSC: An Injury DrugstoreCell Stem Cell, 2011
- Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAsPLOS ONE, 2010
- Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cellsExperimental Hematology, 2010
- Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic HierarchyPLOS ONE, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006